Valeant to sell Dendreon unit to China's Sanpower for $820m

Valeant to sell Dendreon unit to China's Sanpower for $820m

A sign for the headquarters of Valeant Pharmaceuticals International Inc is seen in Laval, Quebec June 14, 2016. REUTERS/Christinne Muschi

Abinaya Vijayaraghavan

10 January, 2017

Sanpower GroupUS Food and Drug Administration (USFDA)Valeant Pharmaceutical International Inc

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.